ANI Pharmaceuticals (BSFA) Q2 2021 Earnings Report
DE:BSFA Q2 2021 EPS Results
- Actual EPS
- EUR 0.60
- Consensus EPS
- EUR 0.54
- Beat/Miss
- Beat by +EUR 0.06
- One Year Ago EPS
- EUR 0.62
DE:BSFA Q2 2021 Revenue Results
- Actual Revenue
- EUR 43.39M
- Expected Revenue
- EUR 41.41M
- Beat/Miss
- Beat by +EUR 1.99M
- YoY Revenue Growth
- +0.32%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/06/2021
- Time
- Before Open
- Conference Call
- Friday, August 6, 2021
DE:BSFA Upcoming Earnings
ANI Pharmaceuticals's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:BSFA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | 1.95- | 1.82 | ― | ― |
| Aug 07, 2026 | 2026 (Q2) | 1.821.97 | 1.61 | 22.78% (+0.37) | |
| May 08, 2026 | 2026 (Q1) | 1.161.83 | 1.52 | 20.59% (+0.31) | |
| Mar 03, 2026 | 2025 (Q4) | 1.782.08 | 1.45 | 42.94% (+0.62) | |
| Nov 10, 2025 | 2025 (Q3) | 1.581.82 | 1.2 | 52.24% (+0.62) | |
| Aug 08, 2025 | 2025 (Q2) | 1.251.61 | 0.91 | 76.47% (+0.70) | |
| May 09, 2025 | 2025 (Q1) | 1.231.52 | 1.08 | 40.50% (+0.44) | |
| Feb 28, 2025 | 2024 (Q4) | 1.281.45 | 0.89 | 63.00% (+0.56) | |
| Nov 08, 2024 | 2024 (Q3) | 0.971.20 | 1.13 | 5.51% (+0.06) | |
| Aug 06, 2024 | 2024 (Q2) | 0.850.91 | 1.14 | -20.31% (-0.23) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed